A Novel Hair Restoration Technology Counteracts Androgenic Hair Loss and Promotes Hair Growth in A Blinded Clinical Trial
January 2023
in “Journal of Clinical Medicine”
TLDR
A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.
A blinded clinical trial involving 20 subjects (4 female, 16 male) over 9 months demonstrated the effectiveness of Tomorrowlabs HIF strengthening factor [HSF] hair restoration technology in treating androgenic alopecia (AGA). The daily application of [HSF] resulted in improvements in hair thickness (+7.2%), hair density (+14.3%), and shine and elasticity (+20.3%). Hair loss was reduced by an average of 66.8% in responsive subjects after 6 months, and hair growth increased up to 32.5%, with an average change of 8.4% in all participants and 10.8% in responsive patients after 9 months. The hair growth cycle was also harmonized, with an average increase of +8.0% in anagen (growth phase) hair and a reduction of -14.0% in telogen (resting phase) hair. The product was found to be safe, beneficial for scalp health, and free of side effects.
View this study on mdpi.com →
Cited in this study
research HIF-1α Stimulators Function Equally to Leading Hair Loss Agents in Enhancing Dermal Papilla Growth
HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.
research A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors
The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.
research Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase
Minoxidil boosts hair growth by increasing blood flow and nutrients to hair follicles.
research Minoxidil Use in Dermatology, Side Effects and Recent Patents
Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.
research New Activators and Inhibitors in the Hair Cycle Clock: Targeting Stem Cells’ State of Competence
research Minoxidil specifically decreases the expression of lysine hydroxylase in cultured human skin fibroblasts
Minoxidil reduces lysine hydroxylase in skin cells.
research Suppression of fibroblast proliferation and lysyl hydroxylase activity by minoxidil.
Minoxidil slows fibroblast growth and collagen production, potentially treating keloids, hypertrophic scars, and connective tissue disorders.
research Effects of Minoxidil on Cultured Human Skin Fibroblasts
Minoxidil slows down skin cell growth and may help treat scars and skin conditions.
Related
research Scalp threading – new treatment option for Androgenetic Alopecia
research Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
Using minoxidil and tofacitinib together can effectively treat severe hair loss.